elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q39881787-1AA8DDD4-EF47-4B0D-A890-79BBF4EB9594
Q39881787-1AA8DDD4-EF47-4B0D-A890-79BBF4EB9594
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39881787-1AA8DDD4-EF47-4B0D-A890-79BBF4EB9594
Emerging drugs to treat Crohn's disease.
P2860
Q39881787-1AA8DDD4-EF47-4B0D-A890-79BBF4EB9594
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39881787-1AA8DDD4-EF47-4B0D-A890-79BBF4EB9594
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ff3356323ecf7f032b01a268c66a49ec98965311
P2860
Risks and benefits of infliximab for the treatment of Crohn's disease